Show simple item record

Limitation of the excessive extracellular matrix turnover is a major determinant of the beneficial effect of spironolactone on survival in patients with CHF: Insights from the RALES trial

dc.contributor.authorZannad, F.en_US
dc.contributor.authorAlla, F.en_US
dc.contributor.authorDousset, B.en_US
dc.contributor.authorPitt, B.en_US
dc.date.accessioned2014-03-05T18:19:10Z
dc.date.available2014-03-05T18:19:10Z
dc.date.issued2000-06en_US
dc.identifier.citationZannad, F.; Alla, F.; Dousset, B.; Pitt, B. (2000). "Limitation of the excessive extracellular matrix turnover is a major determinant of the beneficial effect of spironolactone on survival in patients with CHF: Insights from the RALES trial." European Journal of Heart Failure 2: 98-98. <http://hdl.handle.net/2027.42/106131>en_US
dc.identifier.issn1388-9842en_US
dc.identifier.issn1879-0844en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106131
dc.publisherWiley Periodicals, Inc.en_US
dc.titleLimitation of the excessive extracellular matrix turnover is a major determinant of the beneficial effect of spironolactone on survival in patients with CHF: Insights from the RALES trialen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelCardiovascular Medicineen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106131/1/ejhf80350-5.pdf
dc.identifier.doi10.1016/S1388-9842(00)80350-5en_US
dc.identifier.sourceEuropean Journal of Heart Failureen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.